Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/2003
06/19/2003US20030114493 Antitumor agents
06/19/2003US20030114472 Viricides
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030113274 Comprises anionic and nonionic surfactants such as sodium stearate and sodium palmitate
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469355A1 Mesoporous permeation layers for use on active electronic matrix devices
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1318805A2 Pharmaceutical composition containing citalopram
06/18/2003EP1102747B1 Crystalline forms of osanetant
06/18/2003EP1077984B1 2"-deoxy hygromycin derivatives
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP0936902B1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
06/18/2003CN1425009A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003CA2078605C Chicken anaemia agent vaccine
06/12/2003WO2003047589A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/12/2003WO2003047580A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003047511A2 Use of gingko biloba extracts to promote neuroprotection and reduce weight loss
06/12/2003WO2003047500A2 Vaccine and method for treatment of motor neurone diseases
06/12/2003US20030109691 Variant integrin polypeptides and uses thereof
06/12/2003US20030109551 A therapeutic or preventive agent for pulmonary insufficiency, containing as an active ingredient a diaminotrifluoromethylpyridine derivative represented by the formula (I) or its salt: anti-inflammatory agent or an anti-
06/12/2003US20030109544 Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
06/12/2003US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst
06/12/2003US20030109509 Methods for treating dry eye
06/12/2003US20030109500 Compositions and methods for use in targeting vascular destruction
06/12/2003CA2469092A1 Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als)
06/12/2003CA2468349A1 Pyrimidine compounds
06/12/2003CA2468044A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/11/2003EP1317286A2 Contraception process and administration form for the same
06/11/2003EP1317280A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317279A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317243A1 Hair dyeing agents containing indigo derivatives
06/11/2003EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same
06/11/2003EP1009371B1 Denture cleansing composition
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576657 Amidino derivatives and their use as thrombin inhibitors
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003CA2350195C Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
06/10/2003CA2133427C Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045466A2 Catheter composition and uses thereof
06/05/2003WO2003045412A1 Mint extract and related pharmaceutical compositions
06/05/2003WO2003045392A2 Use of n-(indolcarbonyl-)piperazine derivatives
06/05/2003WO2003045371A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
06/05/2003WO2003045356A1 Pharmaceutical dosage form with multiple coatings
06/05/2003WO2003045329A2 Methods for the purification of levofloxacin
06/05/2003WO2003045319A2 Targeted therapeutics and uses thereof
06/05/2003WO2003045310A2 Digital assay
06/05/2003WO2003026569A3 Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals
06/05/2003US20030105332 Stereoisomers with high affinity for adrenergic receptors
06/05/2003US20030105164 Reacting hexachloroacetone with triphenylphosphine; chlorination of retinoic acid; then aromatic amine; anticancer agents
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/05/2003US20030104603 Citrate lyase polypeptides which are transcriptionally regulated in adipose tissue; fatty acid metabolism; antidiabetic agents; dietetics; drug screening
06/05/2003US20030104081 Composition for treating obesity and esthetic treatment process
06/05/2003US20030103864 Sterilization of pharmaceuticals
06/05/2003CA2468494A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
06/05/2003CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives
06/05/2003CA2467831A1 Mint extract and related pharmaceutical compositions
06/05/2003CA2467645A1 Composition for removing fibrin-bound blood clots from a catheter
06/05/2003CA2466860A1 Methods for the purification of levofloxacin
06/05/2003CA2466821A1 Digital assay
06/05/2003CA2465846A1 Targeted therapeutics and uses thereof
06/04/2003EP1282609A4 Piperazinedione compounds
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422162A Composition and method for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
06/04/2003CN1422161A New combination of a beta blocker and a cholesterol-lowering agent
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/03/2003US6574495 Para-hydrogen labelled agents and their use in magnetic resonance imaging
06/03/2003US6573291 Method and use
06/03/2003CA2275554C Intranasal formulations for treating sexual disorders
05/2003
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003CA2468107A1 Methods for identifying and validating potential drug targets
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/29/2003US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission
05/29/2003US20030100534 Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products
05/29/2003US20030100518 13-Methyl erythromycin derivatives
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100500 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099730 Nutritional supplement and methods of using it
05/29/2003US20030099726 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
05/29/2003US20030099715 Coated pellets of granulated particles containing a drug are charcterized in that a bad taste of the drug when taken by patient is reduced or eliminated, and these pellets also contain an organic carboxylic acid and/or a surfactant
05/29/2003US20030099704 Controlled release oxycodone compositions
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 295